从MGUS/SMM进展为多发性骨髓瘤的亚克隆演化以克隆稳定性为特征
对10例患者系列样本行全外显子测序,分析从意义未明的单克隆丙种球蛋白病(MGUS)和冒烟型多发性骨髓瘤(SMM)进展为症状性多发性骨髓瘤(MM)的亚克隆演化。研究证实诊断时克隆内遗传异质性常见,进展驱动事件较既往报道更细微,MM演化主要以克隆稳定性为特征,MM时转化的亚克隆浆细胞群体在无症状MGUS/SMM阶段已存在。
要点
- 对10例患者系列样本行全外显子测序,覆盖MGUS/SMM至症状性MM的进展过程。
- 诊断时克隆内遗传异质性是多发性骨髓瘤的常见特征。
- MM演化以克隆稳定性为主,MM时的转化亚克隆在MGUS/SMM阶段已存在。
核心结论
- MM演化主要以克隆稳定性为特征,MM时识别的转化亚克隆浆细胞群体在无症状MGUS/SMM阶段已存在。
- 进展驱动事件比既往报道更细微,浆细胞外在因素可能在亚克隆演化和MGUS/SMM向MM进展中发挥作用。
研究设计与样本
- 对10例患者从MGUS/SMM进展至症状性MM的系列样本行全外显子测序。
主要发现
- 诊断时克隆内遗传异质性是多发性骨髓瘤的常见特征。
- 疾病进展涉及的驱动事件比既往报道更细微。
- MM演化主要以克隆稳定性为特征,MM时转化的亚克隆浆细胞群体在无症状MGUS/SMM阶段已存在。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Multiple myeloma (MM) is a largely incurable haematological malignancy defined by the clonal proliferation of malignant plasma cells (PCs) within the bone marrow. Clonal heterogeneity has recently been established as a feature in MM, however, the subclonal evolution associated with disease progression has not been described. Here, we performed whole-exome sequencing of serial samples from 10 patients, providing new insights into the progression from monoclonal gammopathy of undetermined significance (MGUS) and smouldering MM (SMM), to symptomatic MM. We confirm that intraclonal genetic heterogeneity is a common feature at diagnosis and that the driving events involved in disease progression are more subtle than previously reported. We reveal that MM evolution is mainly characterised by the phenomenon of clonal stability, where the transformed subclonal PC populations identified at MM are already present in the asymptomatic MGUS/SMM stages. Our findings highlight the possibility that PC extrinsic factors may play a role in subclonal evolution and MGUS/SMM to MM progression.
引用
- Dutta AK, Fink JL, Grady JP, et al. Subclonal evolution in disease progression from MGUS/SMM to multiple myeloma is characterised by clonal stability. Leukemia. 2018. PMID: 30046162. doi:10.1038/s41375-018-0206-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。